However, different Trp53 mutations, such as Trp53R270H, and other pancreas-specific Cre alleles, such as Ptf1a-Cre (also called p48-Cre), can also be used to drive tumour development in the pancreas. This evidence concerns the gene PTF1A and neoplasm.